Interplay between T helper type 1 and type 2 cytokines and soluble major histocompatibility complex molecules: A paradigm in pregnancy

Immunology

Volumn 107, Issue 3, 2002, Pages 281-287

  Athanassakis, I ^a   Vassiliadis, S ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ALLERGY; ANTIBODY PRODUCTION; AUTOIMMUNITY; CYTOTOXIC T LYMPHOCYTE; DOSE RESPONSE; GENETICS; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; INFECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; PREGNANCY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

CYTOKINES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; PREGNANCY; TH1 CELLS; TH2 CELLS;

EID: 0036435683     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2002.01518.x     Document Type: Review

References (76)

1. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the materno-fetal relatioship: Successful allopregnancy is a Th2 phenomenon. Immunol Today 1993; 14:353-5.
2. Athanassakis I, Bleackley RC, Paetkau V, Guilbert L, Barr PJ, Wegmann TG. The immunostimulatory effect of T cells and T cell lymphokines on murine fetally-derived placental cells. J Immunol 1987; 138:37-44.
3. Chaouat G, Assal Meliani A, Martal J, Raghupathy R, Elliot J, Mosmann T, Wegmann TG. IL-10 prevents inflammatory cytokine-mediated fetal death and is inducible by tau-interferon. J Immunol 1995; 154:4261-8.
4. Chaouat G, Tranchot Diallo J, Volumenie JL, Menu E, Gras G, Delage G, Mognetti B. Immune suppression and Th1/Th2 balance in pregnancy revisited: A (very) personal tribute to Tom Wegmann. Am J Reprod Immunol 1997; 37:427-34.
5. Vassiliadis S, Tsoukatos D, Athanassakis I. Interferon-induced class II expression at the spongiotrophoblastic zone of the murine placenta is linked to fetal rejection and developmental abnormalities. Acta Physiol Scand 1994; 151:485-95.
6. Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ. Cytotoxicity of tumor necrosis factor-alpha and gamma-interferon against primary human trophoblasts. Placenta 1994; 15:819-35.
7. Saito S, Tsukaguchi N, Hasegawa T, Michimata T, Tsuda H, Narita N. Distribution of Th1, Th2 and Th0 and the Th1/Th2 cell ratios in human peripheral and endometrial T cells. Am J Reprod Immunol 1999; 42:240-5.
8. Machelon V, Emilie D. Production of ovarian cytokines and their role in ovulation in the mammalian ovary. Eur Cyt Netw 1997; 8:137-43.
9. Fukuoka M, Yasuda K, Fujiwara H, Kanzaki H, Mori T. Interactions between interferon gamma, tumor necrosis factor alpha, and interleukin 1 in modulating progesterone and oestradiol production by human luteinized granulosa cells in culture. Human Reprod 1992; 7:1361-4.
10. Wang HZ, Lu SH, Han XJ, Zhou W, Sheng WX, Sun ZD, Gong YT. Inhibitory effect of interferon and tumor necrosis factor on human luteal function in vitro. Fertil Steril 1992; 58:941-5.
11. Ozornek MH, Bielfeld P, Krussel JS, Cupisti S, Jeyendran RS, Koldovsky U. Interferon-gamma production by the human pre-implantation embryo. Am J Reprod Immunol 1997; 37:435-7.
12. Athanassakis I, Aifantis I, Baritakis S, Farmakiotis V, Koumantakis E, Vassiliadis S. Nitric oxide production by pre-implantation embryos in response to embryotoxic factors. Cell Physiol Biochem 2000; 10:169-76.
13. Athanassakis I, Papadimitriou L, Bouris G, Vassiliadis S. IFN-gamma induces trophoblast differentiation of ectoplacental cone cells. Dev Comp Immunol 2000; 24:663-72.
14. Athanassakis I, Iconomidou B. Cytokine production in the serum and spleen of mice from day 6-14 of gestation. Dev Immunol 1996; 4:247-55.
15. Methora PK. Ultrastructure of mouse ectoplacental cone cells. Biol Struct Morphogen 1988; 1:63-8.
16. Athanassakis I, Papadimitriou L, Vassiliadis S. Murine ectoplacental cone-derived trophoblast cells express chemokine receptors. J Reprod Immunol 2001; 50:105-19.
17. Athanassakis I, Papadimitriou L, Koumantakis E, Vassiliadis S. Th1 and Th2-type lymphokine-assisted induction and release of chemokine receptors from primary human trophoblast cells. Hum Immunol 2000; 61:651-7.
18. Vassiliadis S, Ranella A, Papadimitriou L, Makrygiannakis A, Athanassakis I. Serum levels of pro- and anti-inflammatory cytokines in non-pregnant women, during pregnancy, labour and abortion. Med Inflamm 1998; 7:69-72.
19. Athanassakis I, Farmakiotis V, Papadimitriou L. Uterine cytokine production during the menstrual cycle and preimplantation stages in mice. Dev Immunol 1999; 7:33-42.
20. Chaouat G, Menu E, Athanassakis I, Wegmann TG. Maternal T cells regulate placental size and fetal survival. Region Immunol 1988; 1:143-8.
21. Athanassakis I, Chaouat G, Wegmann TG. The effects of anti-CD4 and anti-CD8 antibody treatment on placental growth and function in allogeneic and syngeneic murine pregnancy. Cell Immunol 1990; 129:13-21.
22. Jung S, Yaron A, Alkalan I, Hatzubai A, Avraham A, Ben-Neriah Y. Costimulation requirement for AP-1 and NF-κB transcription factor activation in T cells. Ann N Y Acad Sci 1995; 766:245-52.
23. Simpson JL, Elias S. Isolating fetal cells from maternal blood: Advances in prenatal diagnosis through molecular technology. JAMA 1993; 270:2357-61.
24. Wachtel SS, Shulman LP, Sammons D. Fetal cells in the maternal blood. Clin Genet 2001; 59:74-9.
25. Trowsdale J, Barten R, Haude A, Stewart CA, Beck S, Wilson MJ. Genomic context of natural killer receptor extended gene families. Immunol Rev 2001; 181:20-38.
26. Turowski G, Kedzierska A. Soluble HLA class I antigens in serum of healthy individuals-population study. Epidemiology 2000; 6:123-8.
27. Buelow R, Burlingham WJ, Clayberger C. Immunomodulation of soluble HLA class I. Transplantation 1995; 59:649-54.
28. Blasczyk R, Westhoff U, Grosse-Wilde H. Soluble CD4 CD8 and HLA molecules in commercial immunoglobulin presss. Lancet 1993; 341:789-90.
29. Puppo F, Indiveri F, Scudeletti M, Ferrone S. Soluble HLA antigens: New roles and uses. Immunol Today 1997; 18:154-5.
30. Puppo F, Orlandini A, Ruzzenenti R, Comuzio S, Salamito A, Farinelli A, Stagnaro R, Indiveri F. HLA class I soluble antigen serum levels in HIV-positive subject-correlation with cellular and serological parameters. Cancer Detect Prev 1990; 14:321-3.
31. Hagihara M, Shimura T, Takebe K et al. Serum concentrations of soluble HLA-class I and CD8 forms in patients with viral hepatic disorders. J Gastroenterol 1997; 32:338-43.
32. Tambutti ML, Ferraris JR, Redal MA, Ramirez JA, Prigoshin N. Soluble class I antigens in pediatric patients with renal transplants from related living donors without acute rejection and treated with triple therapy. Hum Immunol 1996; 50:135-9.
33. Puppo F, Scudeletti M, Indiveri F, Ferrone S. Soluble HLA class I antigens: Markers and modulators of an immune response? Immunol Today 1995; 16:124-7.
34. Le Morvan C, Cogne M, Drouet M. An elevation in the concentration of HLA class I molecules in human blood due to ageing. Mechan Ageing Devel 2001; 122:335-40.
35. Rebmann V, Passler M, Erhard J, Lange R, Eigler FW, Grosse-Wilde H. Monitoring of soluble HLA class I size variants after liver transplantation. Hum Immunol 1999; 60:424-9.
36. Krangel MS. Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway. J Exp Med 1986; 163:1173-90.
37. DeVito-Haynes LD, Demaria S, Bushkin Y, Burlingham WJ. The metalloproteinase-mediated pathway is essential for generation of soluble HLA class I proteins by activated cells in vitro: Proposed mechanism for soluble HLA release in transplant rejection. Hum Immunol 1998; 59:426-34.
38. Demaria S, Bushkin Y. Soluble HLA proteins with bound peptides are released from the cell surface by the membrane metalloproteinase. Hum Immunol 2000; 61:1332-8.
39. Demaria S, Schwab R, Gottesman SR, Bushkin Y. Soluble beta 2-microglobulin-free class I heavy chains are released from the surface of activated and leukaemia cells by a metalloprotease. J Biol Chem 1994; 269:6689-94.
40. Russwurm GP, Mackler AM, Fagoaga OR, Brown WS 3rd, Sakala EP, Yellon SM, Nehlsen-Cannarella SL. Soluble human leukocyte antigens, interleukin-6, and interferon-gamma during pregnancy. Am J Reprod Immunol 1997; 38:256-62.
41. Inostroza J, Ferrada J, Navarrete C, Sorensen RU. Soluble histocompatibility class I antigens and beta-2microglobulin in pregnant females and cord blood samples. Hum Immunol 1997; 54:63-8.
42. Athanassakis I, Paflis M, Ranella A, Vassiliadis S. Detection of soluble HLA-G levels in maternal serum can be predictive for a successful pregnancy. Transplantation Proc 1999; 31:1834-7.
43. Vassiliadis S, Paflis M, Athanassakis I. Serum-soluble HLA class I and class II levels as an alternative diagnostic test for determining immune indexes required for normal pregnancies. Reprod Fertil Devel 2001; 13:427-33.
44. Vassiliadis S, Athanassakis I. Preventive immunotherapy for high-risk aborters. Rus J Immunol 1998; 3:46-52.
45. Carosella ED, Paul P, Moreau P, Rouas-Freiss N. HLA-G and HLA-E: Fundamental and pathophysiological aspects. Immunol Today 2000; 21:532-4.
46. Carosella ED, Moreau P, Aractingi S, Rouas-Freiss N. HLA-G: A shield against inflammatory aggression. Trends Immunol 2001; 22:553-5.
47. Hunt JS, Jadhav L, Chu W, Geraghty DE, Ober C. Soluble HLA-G circulates in the maternal blood during pregnancy. Am J Reprod Immunol 2000; 183:682-8.
48. Puppo F, Costa M, Contini P, Brenci S, Cevasco E, Ghio M, Norelli R, Bensussan A et al. Determination of soluble HLA-G and HLA-AB, and -C molecules in pregnancy. Transplant Proc 1999; 31:1841-3.
49. Zavazava N, Hausmann R, Muller-Ruchholtz W. Inhibition of anti-HLA-B7 alloreactive CTL by affinity purified soluble HLA. Transplantation 1991; 51:838-42.
50. + cytotoxic T lymphocyte (CTL) activity by soluble HLA class I in vitro. Clin Exp Immunol 2000; 119:107-14.
51. Zavazava N, Kronke M. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes. Nature Med 1996; 2:1005-10.
52. DeVito-Haynes LD, Jankowska-Gan E, Meyer KC, Cornwell RD, Zeevi A, Griffith B, Dauber J, Iacono A et al. Soluble donor HLA class I and beta 2m-free heavy chain in serum of lung transplant recipients: Steady state levels and increase in patients with recurrent CMV infection, acute rejection episodes, and poor outcome. Hum Immunol 2000; 61:1370-82.
53. Zhang ZX, Yang L, Young KJ, DuTemple B, Zhang L. Identification of previously unknown antigen specific regulatory T cell and its mechanism of suppression. Nature Med 2000; 6:782-9.
54. He X, Le J. Alternative splicing of HLA class I transcripts induced by IFN-gamma and TNF in fibroblasts: Release of soluble HLA class I heavy chain and an associated protein. Cell Immunol 1995; 162:159-68.
55. Callahan GN, Ferrone S, Poulik MD, Reisfeld RA, Klein J. Characterization of Ia antigens in mouse serum. J Immunol 1976; 117:1351-5.
56. Wilson BS, Indiveri F, Pellegrino MA, Ferrone S. Production and characterization of DR xenoantisera: Use for detection of serum DR antigens. J Immunol 1979; 122:1967-71.
57. Neubert A, Rebmann V, Steuhl K-P, Heiligenhaus A, Grosse-Wilde H. Soluble HLA class I (sHLA-I) and HLA-DR (sHLA-DR) plasma levels in patients with acute anterior uveitis. In: Proceeding of the 97th German Ophthalmological Society (DOG) on Function Improving and Esthetical Therapy in Ophthalmology. Berlin, Germany, September 23-26, 1999:532. http://www.dog.org/1999/programm/1999_abstracts.html
58. Hosoi K, Hagihara M, Kagawa T, Watanabe N, Matsuzaki S. The serum soluble HLA-DR antigens as a predictive marker in the response to interferon-alpha treatment in patients with chronic hepatitis C. Tokai J Exp Clin Med 2000; 25:117-24.
59. Rebmann V, Dornmair K, Grosse-Wilde H. Biochemical analysis of plasma-soluble invariant chains and their complex formation with soluble HLA-DR. Tissue Antigens 1997; 49:438-42.
60. Athanassakis I, Ranella A, Vassiliadis S. IFN-gamma facilitates release of class II-loaded intracellular pools in trophoblast cells: A novel property independent of protein synthesis. J Interferon Cytok Res 2000; 20:823-30.
61. Athanassakis I, Aifantis Y, Makrygiannakis A, Koumantakis E, Vassiliadis S. Placental tissue from human miscarriages expresses class II MHC antigens. Am J Reprod Immunol 1995; 34:281-7.
62. Athanassakis I. Soluble class I and class II MHC molecules as modulators of the maternal immune response during pregnancy. Am J Reprod Immunol 2001; 46:47-8.
63. Pfeiffer KA, Rebmann V, Passler M, van der Ven K, van der Ven H, Krebs D, Grosse-Wilde H. Soluble HLA levels in early pregnancy after in vitro fertilization. Hum Immunol 2000; 61:559-64.
64. Matalliotakis IM, Athanassakis I, Goumenou AG, Neonaki MA, Koumantakis EE, Vassiliadis S, Koumantakis EE. The possible anti-inflammatory role of circulating human leukocyte antigen levels in women with endometriosis after treatment with danazol and leuprorelin acetate depot. Med Inflamm 2001; 10:75-80.
65. Kanai T, Fujii T, Kosuma S, Yamashita T, Miki A, Kikuchi A, Taketani Y. Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture. Mol Hum Immunol 2001; 7:195-200.
66. Kanai T, Fujii T, Unno N et al. Human leukocyte antigen-G-expressing cells differently modulate the release of cytokines from mononuclear cells present in the decidua versus peripheral blood. Am J Reprod Immunol 2001; 45:94-9.
67. Athanassakis I, Aifantis I, Ranella A, Giouremou K, Vassiliadis S. Inhibition of nitric oxide production rescues LPS-induced fetal abortion in mice. Nitric Oxide 1999; 3:216-24.
68. + T cells inhibit both the induction and effector function of auto-reactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 1998; 160:1212-18.
69. + thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25- and CD25- subpopulations. J Immunol 2000; 165:3105-10.
70. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self tolerance maintained by activated T cells expressing IL-2 receptor alpha chains (CD25). Break-down of a single mechanism of self tolerance causes various autoimmune diseases. J Immunol 1995; 155:1151-64.
71. + T-cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 1997; 389:737-42.
72. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25 (+) CD4 (+) regulatory cells that control intestinal inflammation. J Exp Med 2000; 192:295-302.
73. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, Mak TW, Sakaguchi S. Immunologic self-tolerance maintained by CD25 (+) CD4 (+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192:303-10.
74. + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000; 12:431-40.
75. Coyle AJ, Lehar S, Lloyd C et al. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity 2000; 13:95-105.
76. Hirji N, Lin TJ, Befus AD. Promiscuous CD8: Expression and function of CD8 on macrophages, mast cells and dendritic cells. Mod Asp Immunobiol 2000; 1:140-3.